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Abstract
Activated T lymphocytes of  the Th-1 type are typi-
cally accumulated in the lungs of  patients with sar-
coidosis, and there they may recognize specific sar-
coidosis antigens, presented by antigen presenting
cells such as dendritic cells and/or alveolar macro-
phages. In line with this, previous studies have indi-
cated alveolar macrophages to contain proteins that
could induce granuloma formation. Also, signs of  a
specific immune response in the lungs of  HLA-
-DRB1*0301 positive sarcoidosis patients suggest the
presentation of  specific antigens by HLA class II
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molecules on BAL cells. A number of  peptides have
therefore been eluted from HLA-DR molecules of
BAL cells of  HLA-DRB1*0301 positive sarcoidosis
patients and these peptides are now used in stimula-
tion tests to analyse their capacity to elicit T cell re-
sponses, using an elispot assay. Interestingly, all pep-
tides identified so far were derived from self  proteins,
indicating autoimmune reactions in the lungs of  these
patients. These studies may lead to the identification
of  (a) sarcoidosis specific antigen(s).
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Sarcoidosis is a granulomatous disease of
unknown etiology, commonly affecting the
lungs. Although most patients recover, some
develop chronic disease with in some patients
fibrosis and respiratory failure1. Activated
CD4+ T helper cells accumulate in the lungs
of sarcoidosis patients and there they pro-
duce large amounts of  Th1 associated cy-
tokines (Fig. 1)2-4. A restricted T cell recep-
tor (TCR) repertoire of  the bronchoalveo-
lar lavage (BAL) fluid T cells, with a
preferential expression of  certain TCR α or
Vβ genes, has been reported in several stud-
ies, suggesting T cell reactivity against spe-
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cific sarcoidosis-associated antigens in the
lungs5-9. Especially the strong correlation be-
tween DRB1*0301 and dramatic expansions
of  oligoclonal TCR AV2S3+ CD4+ T cells
in the BAL fluid of  sarcoidosis patients10
strongly indicate that they have been inter-
acting with specific antigens6,11. Altogether,
these findings suggest the presence of  sar-
coidosis specific antigens in the lungs of  the
patients (Fig 2).
Several studies by Drs Y Kataria and J Holter
have indicated the presence of  a factor, called
a granulomagenic factor, capable of  inducing
granulomas in sarcoidosis patients12. By in-
jecting non-viable autologous BAL cells
(NVBC) into the skin of  sarcoidosis patients,
and at the same time injecting Kveim-Silzbach
antigens at other sites, these authors found
that in about half  of  the patients, granulomas
appeared following injections with the NVBC.
Patients with a positive response were those
with a recent onset of  disease, and the granu-
lomas were indistinguishable from granulo-
mas resulting from Kveim-Silzbach antigen
injections. Subsequent studies indicated that
the granulomagenic factor was derived from
alveolar macrophages (AM) rather than BAL
lymphocytes, and the authors could also re-
port granuloma formation following injec-
tions with membrane fractions of  AM. The
granulomagenic factor in these studies hás
been suggested to include sarcoidosis specif-
ic antigens, presented to T cells by AM. For
future studies, intracellular and/or membrane
associated proteins in certain BAL cell sub-
sets such as the alveolar macrophages should
therefore be interesting to study. Such analy-
ses may reveal a distinct protein production
and presentation by the cells, which might
relate to the specific inflammatory process
seen in sarcoidosis.
In our search for sarcoidosis-specific antigens,
we set out to identify peptides presented by
HLA-DR molecules of  BAL cells of  patients
with sarcoidosis. Since we previously found
signs of  a specific immune response in HLA-
-DRB1*0301 positive patients, we focused on
this particular subset of  patients, and pooled
BAL cells of  15 DRB1*0301 positive sar-
coidosis patients. In collaboration with Dr. R
Weissert and Dr. H-G Rammensee at the
University of  Tübingen, Germany, HLA class
ll-bound peptides were isolated according to
standard protocols, using an HLA-DR spe-
cific antibody, acid treatment, ultrafiltration
and fractionation by HPLC (Fig. 3). Peptide-
-containing HPLC fractions were pooled and
aliquots analyzed by nanocapillary HPLC elec-
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Fig. 1 – Lung accumulated T cells typically produce Th-1
associated cytokines.
Fig. 2 – Specific antigen presentation by HLA-DRB1*0301
molecules and antigen recognition by T cells expressing
the TCR AV2S3 gene segment.
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trospray ionization (HPLC ES) MS. Peptide
mass fingerprints were analyzed manually for
identification of  a tentative amino acid se-
quence. We have identified 87 definite amino
acid sequences derived from 38 different hu-
man proteins as defined by data base search-
es performed in collaboration with Dr B Pers-
son at the Centre for Genomics &
Bioinformatics, Kl. All the identified proteins
are self-proteins, involved in antigen process-
ing and presentation, from cell surface recep-
tors, cytoskeletal proteins, enzymes, house-
keeping proteins, serum proteins or various
(e.g. surfactant) proteins.
Our data on peptides identified from BAL
cells of  DRB1*0301 positive sarcoidosis
patients is for the first time showing what
antigens are locally presented during a pul-
monary inflammatory condition. Several of
these were normally abundant proteins such
as albumin. Other proteins, such as some
intracellular enzymes, could better be antici-
pated to serve as targets for autoimmune at-
tacks and in fact one of  these proteins is in a
HLA-DRB1*0301-associated way involved
in pulmonary inflammation connected to
another autoimmune disease. We now use
these candidate antigens in stimulation tests
to elucidate their role in the pathogenesis of
sarcoidosis. A few of  the tested peptides are
in fact capable of  stimulating T cells of  sar-
coidosis patients, but not controls, to pro-
duce IFNy. Although laborious, these stud-
ies may lead to the identification of
sarcoidosis-specific antigen(s).
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Fig. 3 – HLA-DR molecules were separated, using HLA-DR specific antibodies, and antigen peptides were eluted, according
to Standard protocols. Peptides were then separated and sequenced.
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